Equities

Neuroone Medical Technologies Corp

NMTC:NAQ

Neuroone Medical Technologies Corp

Actions
FinancialsInvestment Banking and Brokerage Services
  • Price (USD)1.08
  • Today's Change0.03 / 2.86%
  • Shares traded41.57k
  • 1 Year change-16.92%
  • Beta1.0003
Data delayed at least 15 minutes, as of May 17 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.

  • Revenue in USD (TTM)2.86m
  • Net income in USD-13.47m
  • Incorporated2017
  • Employees16.00
  • Location
    Neuroone Medical Technologies Corp7599 Anagram DrEDEN PRAIRIE 55344-7399United StatesUSA
  • Phone+1 (952) 426-1383
  • Fax+1 (302) 655-5049
  • Websitehttps://nmtc1.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Neuraxis Inc2.46m-14.63m20.05m17.00------8.15-3.78-3.780.5432------------------87.67---594.57-----23.75-----8.37---163.78------
REMSleep Holdings Inc203.73k-1.78m24.70m6.00--26.76--121.25-0.0012-0.00120.00010.00060.08921.6619.66---77.85-152.40-92.09-317.98-371.44---872.65-2,317.523.18-353.980.00---36.48--12.13--28.26--
Ekso Bionics Holdings Inc17.91m-14.24m24.72m70.00--1.75--1.38-0.9685-0.96851.200.77650.54231.653.38255,900.00-43.11-43.63-57.86-57.6750.4151.93-79.48-104.242.11-34.630.2937--41.5710.03-0.7825--3.69--
SANUWAVE Health Inc22.41m-17.26m25.21m31.00------1.13-0.0267-0.02670.0238-0.04171.103.607.50722,838.70-84.54-136.54----71.6369.13-77.00-189.600.11930.0192----21.8461.61-150.72------
Femasys Inc1.05m-14.90m28.22m32.00--1.80--26.90-0.8567-0.85670.05880.70630.05490.49398.5832,785.00-77.93---86.46--65.35---1,420.27--8.02--0.3057---11.13---25.04------
SeaStar Medical Holding Corp0.00-26.23m29.13m12.00---------1.28-1.280.00-0.29130.00----0.00-800.85-----------------26.51---------115.19------
Neuroone Medical Technologies Corp2.86m-13.47m29.72m16.00--6.07--10.40-0.6922-0.69220.14240.17790.3691.668.94178,516.30-174.02-172.88-211.08-274.7427.16---471.65-674.972.52--0.00--62.66---18.60------
Retractable Technologies Inc40.20m-7.80m30.54m148.00--0.3071--0.7597-0.2607-0.26071.343.330.21751.545.85271,589.10-4.1012.45-4.3014.5120.2540.82-18.8418.098.18-2.900.0145---54.025.55-249.46--17.42--
Positron Corp1.24m-1.27m31.12m22.00------25.15-0.0897-0.08970.0876-0.11090.59762.296.56---61.35-224.13----32.989.85-102.67-201.870.0638-------10.060.275163.63--4.36--
Harvard Apparatus Regenertv Tchnlgy Inc103.00k-9.02m32.92m10.00--19.49--319.66-0.6801-0.68010.00770.1180.0411----10,300.00-356.80-330.30-666.79-1,524.8876.70---8,684.47-35,138.840.7572--0.00-------44.28---39.07--
Akili Inc1.95m-48.55m33.45m36.00--0.667--17.17-0.6201-0.62010.02490.63810.0203--20.1928,647.06-50.58---57.34--56.11---2,492.04-----25.510.1835--419.50---212.48------
BioRegenx Inc22.24k-571.17k33.48m10.00------1,505.49-0.0021-0.00210.00008-0.00080.4899----2,224.00-1,258.22------96.85---2,568.21-----13.2366.29---47.25---629.37------
Co-Diagnostics Inc6.68m-38.89m34.07m155.00--0.4351--5.10-1.32-1.320.22682.510.06561.144.2643,083.48-38.195.77-39.936.1541.3482.24-582.3610.949.90--0.000.00-80.09179.54-148.15--101.27--
Precision Optics Corporation Inc19.22m-1.72m38.96m84.00--3.44--2.03-0.289-0.2893.271.871.094.315.09228,782.90-9.77-6.71-13.54-10.5533.3533.65-8.94-5.021.10-10.390.1823--34.2339.1284.42--19.39--
Data as of May 17 2024. Currency figures normalised to Neuroone Medical Technologies Corp's reporting currency: US Dollar USD

Institutional shareholders

24.89%Per cent of shares held by top holders
HolderShares% Held
Manchester Management Co. LLCas of 25 Jan 20242.36m9.12%
AWM Investment Co., Inc.as of 31 Mar 20241.45m5.59%
Nantahala Capital Management LLCas of 31 Mar 20241.20m4.62%
The Vanguard Group, Inc.as of 31 Mar 2024919.32k3.55%
Geode Capital Management LLCas of 31 Mar 2024221.95k0.86%
Perkins Capital Management, Inc.as of 31 Mar 2024150.00k0.58%
SSgA Funds Management, Inc.as of 31 Mar 202451.60k0.20%
MAI Capital Management LLCas of 31 Mar 202450.00k0.19%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 202430.28k0.12%
Virtu Americas LLCas of 31 Dec 202318.12k0.07%
More ▼
Data from 31 Dec 2023 - 09 May 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.